Patients with a specific type of heart failure were less active when taking a commonly prescribed nitrate medication thought to improve exercise capacity, according to a recent study co-authored by Northwestern Medicine investigator Sanjiv Shah, MD.
Sen. Dick Durbin visited Feinberg to highlight importance of medical research and discussed a $2 billion increase in funding for the National Institutes of Health in 2016.
A new Northwestern Medicine study led by Navdeep Chandel, PhD, challenges the common understanding that energy production is mitochondria’s most important function.
Northwestern Medicine scientists have received a five-year, $11 million grant from the National Institutes of Health National Cancer Institute (NCI) to lead a Specialized Program of Research Excellence (SPORE) in prostate cancer.
Northwestern researchers collaborate across fields and disciplines to use every means possible to fight HIV/AIDS.
From the junctions that hold cells together to the bacteria that cause pneumonia, fascinating scientific images provide a window into the wide range of research that Feinberg faculty, trainees and students published in 2015.
Northwestern Medicine scientists discovered that nitric oxide is part of a new form of cell learning in the striatum, the region of the brain involved in the symptoms of Parkinson’s disease and schizophrenia.
A randomized clinical trial showed an intravitreous drug may be an alternative treatment for some patients with proliferative diabetic retinopathy.
A recent study co-authored by Northwestern Medicine scientist Robert Goldman, PhD, and colleagues suggests that degradation of lamin B1, a protein located in the nucleus of cells, helps suppress tumor formation.
A brain region controlling whether we feel happy or sad, as well as addiction, is remodeled by chronic pain, according to a new Northwestern Medicine study, and a new treatment targeting this region may dramatically lessen symptoms.